PUBLIC POLICY STATEMENT ON OPIOID ANTAGONIST AGENT DETOXIFICATION UNDER SEDATION OR ANESTHESIA (OADUSA)
Պահպանված է:
AMERICAN SOCIETY OF ADDICTION MEDICINE, PUBLIC POLICY STATEMENT ON OPIOID ANTAGONIST AGENT DETOXIFICATION UNDER SEDATION OR ANESTHESIA (OADUSA). JOURNAL OF ADDICTIVE DISEASES, Vol. 19, no. 4 (2000), p. 109-112.
Ref.
98719
Տեղադրություն:
SIIS R.926
Palabras clave:
Antagonistas, Desintoxicación, Drogodependencias, Naltrexona, Opiáceos, Recomendaciones, Tratamiento
Antagonistas, Desintoxicación, Drogodependencias, Naltrexona, Opiáceos, Recomendaciones, Tratamiento
Նմանատիպ նյութեր: PUBLIC POLICY STATEMENT ON OPIOID ANTAGONIST AGENT DETOXIFICATION UNDER SEDATION OR ANESTHESIA (OADUSA)
- PLASMA NALTREXONE DURING OPIOID DETOXIFICATION
- A COMPARISON OF ANTAGONIST-PRECIPITATED WITHDRAWAL UNDER ANESTHESIA TO STANDARD INPATIENT WITHDRAWAL AS A PRECURSOR TO MAINTENANCE NALTREXONE TREATMENT IN HEROIN USERS: OUTCOMES AT 6 ANS 12 MONTHS
- NALTREXONE SHORTENED OPIOID DETOXIFICATION WITH BUPRENORPHINE
- CLONIDINE AND OPIATE RECEPTOR ANTAGONISTS IN THE TREATMENT OF HEROIN ADDICTION
- OPIOID ANTAGONIST DETOXIFICATION UNDER ANAESTHESIA VERSUS TRADITIONAL CLONIDINE DETOXIFICATION COMBINED WITH AN ADDICTIONAL WEEK OF PSYCHOSOCIAL SUPPORT: A RANDOMISED CLINICAL TRIAL
- COMPLIANCE TO NALTREXONE TREATMENT AFTER ULTRA-RAPID OPIATE DETOXIFICATION: AN OPEN LABEL NATURALISTIC STUDY